{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:41:34Z","timestamp":1789684894277,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10359-9","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T06:58:59Z","timestamp":1740725939000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["mir-188\u20105p emerges as an oncomir to promote chronic myeloid leukemia via upregulation of BUB3 and SUMO2"],"prefix":"10.1007","volume":"52","author":[{"given":"Osman","family":"Akidan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sema","family":"Misir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"10359_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-016-0518-2","volume":"15","author":"CH Yeh","year":"2016","unstructured":"Yeh CH, Moles R, Nicot C (2016) Clinical significance of microRNAs in chronic and acute human leukemia. Mol Cancer 15:1\u201316","journal-title":"Mol Cancer"},{"key":"10359_CR2","unstructured":"Baik H (2017) Role of the SUMO pathway in Acute Myeloid Leukemias response to treatments Doctoral dissertation, Universit\u00e9 Montpellier"},{"issue":"24","key":"10359_CR3","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.2217\/bmm-2023-0575","volume":"17","author":"M Parsa-Kondelaji","year":"2023","unstructured":"Parsa-Kondelaji M, Musavi M, Barzegar F et al (2023) Dysregulation of miRNA expression in patients with chronic myelogenous leukemia at diagnosis: a systematic review. Biomark Med 17(24):1021\u20131029","journal-title":"Biomark Med"},{"key":"10359_CR4","doi-asserted-by":"crossref","unstructured":"Pinnenti M, Sami MA, Hassan U (2024) Enabling biomedical technologies for chronic myelogenous leukemia (CML) biomarkers detection. Biomicrofluidics 18(1)","DOI":"10.1063\/5.0172550"},{"issue":"1","key":"10359_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00018-023-05036-8","volume":"81","author":"X Zhang","year":"2024","unstructured":"Zhang X, Ma W, Xue W et al (2024) miR-181a plays the tumor-suppressor role in chronic myeloid leukemia CD34\u2009+\u2009cells partially via SERPINE1. Cell Mol Life Sci 81(1):10","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10359_CR6","doi-asserted-by":"publisher","first-page":"2244856","DOI":"10.1080\/16078454.2023.2244856","volume":"8","author":"Y Yang","year":"2023","unstructured":"Yang Y, Zhong F, Jiang J et al (2023) Bioinformatic analysis of the expression profile and identification of RhoGDI2 as a biomarker in imatinib-resistant K562 cells. Hematology 8(1):2244856","journal-title":"Hematology"},{"issue":"3","key":"10359_CR7","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1007\/s11033-021-06281-5","volume":"48","author":"S Misir","year":"2021","unstructured":"Misir S, Hepokur C, Aliyazicioglu Y, Enguita FJ (2021) Biomarker potentials of miRNA-associated circRNAs in breast cancer (MCF-7) cells: an in vitro and in silico study. Mol Biol Rep 48(3):2463\u20132471","journal-title":"Mol Biol Rep"},{"issue":"4","key":"10359_CR8","doi-asserted-by":"publisher","first-page":"102092","DOI":"10.1016\/j.jogoh.2021.102092","volume":"50","author":"S Misir","year":"2021","unstructured":"Misir S, Hepokur C, Oksasoglu B, Yildiz C, Yanik A, Aliyazicioglu Y (2021) Circulating serum miR-200c and miR-34a-5p as diagnostic biomarkers for endometriosis. J Gynecol Obstet Hum Reprod 50(4):102092","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"5","key":"10359_CR9","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.3390\/ijms21051723","volume":"21","author":"Z Ali Syeda","year":"2020","unstructured":"Ali Syeda Z, Langden SSS, Munkhzul C, Lee M, Song SJ (2020) Regulatory mechanism of MicroRNA expression in cancer. Int J Mol Sci 21(5):1723","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10359_CR10","doi-asserted-by":"publisher","first-page":"e0118099","DOI":"10.1371\/journal.pone.0118099","volume":"10","author":"S Jinlong","year":"2015","unstructured":"Jinlong S, Lin F, Yonghui L, Li Y, Weidong W (2015) Identification of let-7a-2-3p or\/and mir-188-5p as prognostic biomarkers in cytogenetically normal acute myeloid leukemia. PLoS ONE 10(2):e0118099","journal-title":"PLoS ONE"},{"key":"10359_CR11","doi-asserted-by":"publisher","first-page":"120437","DOI":"10.1016\/j.lfs.2022.120437","volume":"296","author":"A Navabi","year":"2022","unstructured":"Navabi A, Akbari B, Abdalsamadi M, Naseri S (2022) The role of microRNAs in the development, progression and drug resistance of chronic myeloid leukemia and their potential clinical significance. Life Sci 296:120437","journal-title":"Life Sci"},{"issue":"4","key":"10359_CR12","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.jhep.2015.05.008","volume":"63","author":"F Fang","year":"2015","unstructured":"Fang F, Chang RM, Yu L et al (2015) MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma. J Hepatol 63(4):874\u2013885","journal-title":"J Hepatol"},{"key":"10359_CR13","doi-asserted-by":"crossref","unstructured":"Zhang H, Qi S, Zhang T et al (2015) Mir-188\u20105p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression. Oncotarget 6:6092\u20106104.","DOI":"10.18632\/oncotarget.3341"},{"key":"10359_CR14","doi-asserted-by":"crossref","unstructured":"Lu N, Wang X, Wang W et al (2023) TET1-mediated microRNA-188-5p promoter hydroxymethylation regulates PTEN\/PI3K\/AKT signaling pathway in acute myeloid leukemia cells. Arch Biochem Biophys 736.109523.","DOI":"10.1016\/j.abb.2023.109523"},{"key":"10359_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-018-5219-3","volume":"19","author":"Y Li","year":"2019","unstructured":"Li Y, Yan X, Shi J et al (2019) Aberrantly expressed mir-188-5p promotes gastric cancer metastasis by activating Wnt\/\u03b2-catenin signaling. BMC Cancer 19:1\u201315","journal-title":"BMC Cancer"},{"issue":"12","key":"10359_CR16","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1158\/1535-7163.MCT-19-0051","volume":"18","author":"ZY Nie","year":"2019","unstructured":"Nie ZY, Yang L, Liu XJ et al (2019) Morin inhibits proliferation and induces apoptosis by modulating the miR-188-5p\/PTEN\/AKT regulatory pathway in CML cells. Mol Cancer Ther 18(12):2296\u20132307","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"10359_CR17","doi-asserted-by":"publisher","first-page":"15027","DOI":"10.1002\/jcb.28764","volume":"120","author":"M Wang","year":"2019","unstructured":"Wang M, Qiu R, Gong Z et al (2019) Mir-188\u20105p emerges as an oncomiRNA to promote gastric cancer cell proliferation and migration via upregulation of SALL4. J Cell Biochem 120(9):15027\u201315037","journal-title":"J Cell Biochem"},{"key":"10359_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fmolb.2017.00046","volume":"4","author":"K Zhou","year":"2017","unstructured":"Zhou K, Liu M, Cao Y (2017) New insight into microRNA functions in cancer: oncogene\u2013microRNA\u2013tumor suppressor gene network. Front Mol Biosci 4:46","journal-title":"Front Mol Biosci"},{"issue":"5","key":"10359_CR19","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3390\/pharmaceutics14051084","volume":"14","author":"PM Silva","year":"2022","unstructured":"Silva PM, Bousbaa H (2022) BUB3, beyond the simple role of Partner. Pharmaceutics 14(5):1084","journal-title":"Pharmaceutics"},{"issue":"5","key":"10359_CR20","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/cbin.11740","volume":"46","author":"C Wang","year":"2022","unstructured":"Wang C, Cheng D, Pan C, Wang C, Nie Z (2022) Research progress of Bub3 gene in malignant tumors. Cell Biol Int 46(5):673\u2013682","journal-title":"Cell Biol Int"},{"issue":"6","key":"10359_CR21","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/2211-5463.13173","volume":"11","author":"J Chen","year":"2021","unstructured":"Chen J, Chen C, Lin Y et al (2021) Downregulation of SUMO2 inhibits hepatocellular carcinoma cell proliferation, migration and invasion. FEBS Open Bio 11(6):1771\u20131784","journal-title":"FEBS Open Bio"},{"issue":"4","key":"10359_CR22","first-page":"1081","volume":"52","author":"ZJ Han","year":"2018","unstructured":"Han ZJ, Feng YH, Gu BH, Li YM, Chen H (2018) The post-translational modification, SUMOylation, and cancer. Int J Oncol 52(4):1081\u20131094","journal-title":"Int J Oncol"},{"issue":"4","key":"10359_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2021.12535","volume":"21","author":"P Wang","year":"2021","unstructured":"Wang P, Xue N, Zhang C et al (2021) Inhibition of SUMO2\/3 antagonizes isoflurane\u2013induced cancer\u2013promoting effect in hepatocellular carcinoma Hep3B cells. Oncol Lett 21(4):1\u20131","journal-title":"Oncol Lett"},{"key":"10359_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-8722-6-54","volume":"6","author":"K Sweet","year":"2013","unstructured":"Sweet K, Zhang L, Pinilla-Ibarz J (2013) Biomarkers for determining the prognosis in chronic myelogenous leukemia. J Hematol Oncol 6:1\u20139","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10359_CR25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE (2002) Gene expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30(1):207\u2013210","journal-title":"Nucleic Acids Res"},{"issue":"30","key":"10359_CR26","doi-asserted-by":"publisher","first-page":"49451","DOI":"10.18632\/oncotarget.17706","volume":"8","author":"S Salati","year":"2017","unstructured":"Salati S, Salvestrini V, Carretta C et al (2017) Deregulated expression of miR-29a-3p, mir-494-3p and mir-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells. Oncotarget 8(30):49451\u201349469","journal-title":"Oncotarget"},{"key":"10359_CR27","doi-asserted-by":"crossref","unstructured":"Bao M, Jiang G (2019) Differential expression and functional analysis of lung cancer gene expression datasets: a systems biology perspective. Oncol Lett 776\u2013782","DOI":"10.3892\/ol.2019.10362"},{"key":"10359_CR28","doi-asserted-by":"publisher","first-page":"W244","DOI":"10.1093\/nar\/gkaa467","volume":"48","author":"L Chang","year":"2020","unstructured":"Chang L, Zhou G, Soufan O, Xia J (2020) miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology. Nucleic Acids Res 48:W244\u2013W251","journal-title":"Nucleic Acids Res"},{"key":"10359_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X (2020) miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res 48:127\u2013131","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"10359_CR30","doi-asserted-by":"publisher","first-page":"D900","DOI":"10.1093\/nar\/gky939","volume":"47","author":"H Yuan","year":"2019","unstructured":"Yuan H, Yan M, Zhang G et al (2019) CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res 47(D1):D900\u2013D908","journal-title":"Nucleic Acids Res"},{"key":"10359_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/pro.3978","volume":"30","author":"R Oughtred","year":"2021","unstructured":"Oughtred R, Rust J, Chang C et al (2021) The BioGRID database: a comprehensive biomedical resource of curated protein, genetic, and chemical interactions. Protein Sci 30:187\u2013200","journal-title":"Protein Sci"},{"key":"10359_CR32","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-farley","year":"2010","unstructured":"Warde-farley D, Donaldson SL, Comes O et al (2010) The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 38:214\u2013220","journal-title":"Nucleic Acids Res"},{"key":"10359_CR33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402\u2013408","journal-title":"Methods"},{"issue":"1","key":"10359_CR34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","volume":"13","author":"N Zhang","year":"2023","unstructured":"Zhang N, Wu J, Wang Q et al (2023) Global burden of hematologic malignancies and evolution patterns over the past 30 years. Blood Cancer J 13(1):82","journal-title":"Blood Cancer J"},{"key":"10359_CR35","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1021\/acs.molpharmaceut.8b00071","volume":"15","author":"L Zhao","year":"2018","unstructured":"Zhao L, Ni X, Zhao L et al (2018) MiroRNA-188 acts as tumor suppressor in non-small-cell lung cancer by targeting MAP3K3. Mol Pharm 15:1682\u20131689","journal-title":"Mol Pharm"},{"issue":"3","key":"10359_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.14715\/cmb\/2023.69.3.9","volume":"69","author":"H Zhang","year":"2023","unstructured":"Zhang H, Yuan N, Che H, Cheng X (2023) Mir-188-5p inhibits cell proliferation and migration in ovarian cancer via competing for CCND2 with ELAVL1. Cell Mol Biol 69(3):69\u201374","journal-title":"Cell Mol Biol"},{"key":"10359_CR37","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1186\/s12885-023-10901-7","volume":"23","author":"B Wu Yh, Yu","year":"2023","unstructured":"Wu Yh, Yu B, Zhou J et al (2023) MicroRNA-188-5p inhibits hepatocellular carcinoma proliferation and migration by targeting forkhead box N2. BMC Cancer 23:511","journal-title":"BMC Cancer"},{"issue":"27","key":"10359_CR38","doi-asserted-by":"publisher","first-page":"42683","DOI":"10.18632\/oncotarget.7977","volume":"7","author":"C Chakraborty","year":"2016","unstructured":"Chakraborty C, Sharma AR, Patra BC et al (2016) MicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemia. Oncotarget 7(27):42683","journal-title":"Oncotarget"},{"issue":"5","key":"10359_CR39","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s40291-017-0285-9","volume":"21","author":"N Petrovic","year":"2017","unstructured":"Petrovic N, Erg\u00fcn S, Isenovic ER (2017) Levels of MicroRNA Heterogeneity in Cancer Biology. Mol Diagn Ther 21(5):511\u2013523","journal-title":"Mol Diagn Ther"},{"issue":"11","key":"10359_CR40","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1182\/blood-2016-10-697698","volume":"130","author":"JA Wallace","year":"2017","unstructured":"Wallace JA, Connell RMO (2017) MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts. Blood 130(11):1290\u20131301","journal-title":"Blood"},{"key":"10359_CR41","first-page":"801","volume":"53","author":"S Cheng","year":"2020","unstructured":"Cheng S, Xia Y, Zhang M et al (2020) Downregulation of microRNA-188-5p suppresses proliferative and invasive abilities of cutaneous squamous cell carcinoma cells by regulating the PTEN\/Akt pathway. Chin J Dermatology 53:801\u2013806","journal-title":"Chin J Dermatology"},{"key":"10359_CR42","doi-asserted-by":"crossref","unstructured":"Valinezhad Orang A, Safaralizadeh R, Kazemzadeh-Bavili M (2014) Mechanisms of miRNA-Mediated Gene Regulation from Common Downregulation to mRNA-Specific Upregulation. Int J Genomics 2014:970607","DOI":"10.1155\/2014\/970607"},{"issue":"12","key":"10359_CR43","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.3390\/cancers12123854","volume":"12","author":"IA Elcheva","year":"2020","unstructured":"Elcheva IA, Spiegelman VS (2020) The role of cis- and trans-acting RNA Regulatory Elements in Leukemia. Cancers (Basel) 12(12):3854","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10359_CR44","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/wrna.121","volume":"3","author":"S Vasudevan","year":"2012","unstructured":"Vasudevan S (2012) Posttranscriptional upregulation by microRNAs. Wiley Interdiscip Rev RNA 3(3):311\u2013330","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"10","key":"10359_CR45","first-page":"1260","volume":"27","author":"H Liu","year":"2024","unstructured":"Liu H, Chen H, Zhang X et al (2024) MicroRNA Mir-188-5p enhances SUMO2\/3 conjugation by targeting SENP3 and alleviates focal cerebral ischemia\/reperfusion injury in rats. Iran J Basic Med Sci 27(10):1260","journal-title":"Iran J Basic Med Sci"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10359-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10359-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10359-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:24:28Z","timestamp":1766852668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10359-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10359"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10359-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"3 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval of the research protocol by an Institutional Reviewer Board: N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Registry and the registration no. of the study\/trial"}},{"value":"N\/A.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"269"}}